Any feedback?
Literature summary extracted from
- Caffeine stimulates cytochrome oxidase expression and activity in the striatum in a sexually dimorphic manner (2008), Mol. Pharmacol., 74, 673-684.
Activating Compound
| EC Number | Activating Compound | Comment | Organism | Structure |
|---|---|---|---|---|
| 7.1.1.9 | Caffeine | increases Cox7c mRNA expression in PC-12 cells. This occurrs at the level of transcription and is mediated by a segment of the Cox7c promoter | Rattus norvegicus |  |
| 7.1.1.9 | Caffeine | increases Cox7c mRNA expression in the male striatum. Cox7c is up-regulated in the striatum of male but not female mice after receiving a single dose of caffeine. Cox1 and Cox4 are also stimulated by caffeine in a male-specific fashion. A2AR-specific agonist 2-[p-(2-carboxyethyl)phenethylamino]-5'-N-ethylcarboxamidoadenosine counteracts the elevation of Cox expression and activity by caffeine | Mus musculus | |
| 7.1.1.9 | SCH58261 | A2AR antagonist, which stimulates Cox expression and activity | Mus musculus | |
| 7.1.1.9 | siRNA | knockdown of Cox7c expression in PC-12 cells blunts Cox activity, which is counteracted by caffeine treatment | Rattus norvegicus |
Application
| EC Number | Application | Comment | Organism |
|---|---|---|---|
| 7.1.1.9 | medicine | cytochrome oxidase is a metabolic target of caffeine. Stimulation of Cox activity by caffeine via blockade of A2AR signaling may be an important mechanism underlying the therapeutic benefits of caffeine in Parkinsons disease | Rattus norvegicus |
| 7.1.1.9 | medicine | cytochrome oxidase is a metabolic target of caffeine. Stimulation of Cox activity by caffeine via blockade of A2AR signaling may be an important mechanism underlying the therapeutic benefits of caffeine in Parkinsons disease | Mus musculus |
Localization
| EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
|---|---|---|---|---|---|
| 7.1.1.9 | inner membrane | - |
Mus musculus | - |
- |
| 7.1.1.9 | mitochondrion | - |
Mus musculus | 5739 | - |
Molecular Weight [Da]
| EC Number | Molecular Weight [Da] | Molecular Weight Maximum [Da] | Comment | Organism |
|---|---|---|---|---|
| 7.1.1.9 | 5444 | - |
Cox7c, mass spectrometry | Mus musculus |
| 7.1.1.9 | 18000 | - |
Cox4, immunoblot analysis | Mus musculus |
| 7.1.1.9 | 35000 | - |
Cox1, immunoblot analysis | Mus musculus |
Organism
| EC Number | Organism | UniProt | Comment | Textmining |
|---|---|---|---|---|
| 7.1.1.9 | Mus musculus | P17665 | C57B6/S129 mice | - |
| 7.1.1.9 | Mus musculus C57B6 / S129 | P17665 | C57B6/S129 mice | - |
| 7.1.1.9 | Rattus norvegicus | - |
- |
- |
Purification (Commentary)
| EC Number | Purification (Comment) | Organism |
|---|---|---|
| 7.1.1.9 | partially purified by gel filtration | Mus musculus |
Source Tissue
| EC Number | Source Tissue | Comment | Organism | Textmining |
|---|---|---|---|---|
| 7.1.1.9 | additional information | striatum | Mus musculus | - |
| 7.1.1.9 | PC-12 cell | - |
Rattus norvegicus | - |
Substrates and Products (Substrate)
| EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
|---|---|---|---|---|---|---|---|
| 7.1.1.9 | 3,3'-diaminobenzidene-tetrahydrochloride + O2 + H+ | - |
Rattus norvegicus | ? + H2O | - |
? | |
| 7.1.1.9 | 3,3'-diaminobenzidene-tetrahydrochloride + O2 + H+ | - |
Mus musculus | ? + H2O | - |
? | |
| 7.1.1.9 | 3,3'-diaminobenzidene-tetrahydrochloride + O2 + H+ | - |
Mus musculus C57B6 / S129 | ? + H2O | - |
? | |
Synonyms
| EC Number | Synonyms | Comment | Organism |
|---|---|---|---|
| 7.1.1.9 | COX | - |
Rattus norvegicus |
| 7.1.1.9 | COX1 | - |
Mus musculus |
| 7.1.1.9 | COX4 | - |
Mus musculus |
| 7.1.1.9 | Cox7c | - |
Mus musculus |
| 7.1.1.9 | cytochrome oxidase | - |
Rattus norvegicus |
| 7.1.1.9 | cytochrome oxidase | - |
Mus musculus |
| 7.1.1.9 | cytochrome oxidase VIIc | - |
Mus musculus |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
